|Articles|February 4, 2009
Spectral domain OCT for drusen evaluation
Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular age-related macular degeneration
Advertisement
Please click
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Retinal imaging as a window into atrial fibrillation
2
The Wills Retina Report: Mapping gene therapy for wet AMD with Carl D. Regillo, MD, and Allen C. Ho, MD
3
OCT-980 receives FDA orphan drug designation for retinitis pigmentosa
4
First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP
5














